{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:48:09Z","timestamp":1780667289331,"version":"3.54.1"},"reference-count":53,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Cystic fibrosis (CF) is the most common autosomal recessive disease among Caucasians. Over the last 20 years, culture-independent analysis, including next-generation sequencing, has paired with culture-based microbiology, offering deeper insight into CF lung and gut microbiota. The aim of this review is to analyse the features of gut microbiota in patients with CF and its possible role in the progression of the disease, establishing the basis for a potential role in microbe-based therapies. The literature analysis showed that the gut environment in CF patients has unique features due to the characteristics of the disease, such as decreased bicarbonate secretion, increased luminal viscosity, and an acidic small intestinal environment, which, due to the treatment, includes regular antibiotic use or a high-energy and fat-dense diet. As a result, the gut microbial composition appears altered, with reduced richness and diversity. Moreover, the population of pro-inflammatory bacteria is higher, while immunomodulatory genera, such as Bacteroides and Bifidobacterium, are scarcer. The imbalanced gut microbial population has a potential role in the development of systemic inflammation and may influence clinical outcomes, such as respiratory exacerbations, spirometry results, and overall growth. Although a better understanding of the pathophysiology behind the gut\u2013lung axis is needed, these findings support the rationale for considering gut microbiota manipulation as a possible intervention to regulate the severity and progression of the disease.<\/jats:p>","DOI":"10.3390\/microorganisms11010009","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:31:06Z","timestamp":1671593466000},"page":"9","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Gut Dysbiosis in Children with Cystic Fibrosis: Development, Features and the Role of Gut\u2013Lung Axis on Disease Progression"],"prefix":"10.3390","volume":"11","author":[{"given":"Ilaria","family":"Testa","sequence":"first","affiliation":[{"name":"Respiratory Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 1LE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2800-7864","authenticated-orcid":false,"given":"Oliviero","family":"Crescenzi","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London WC1N 1LE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[{"name":"Paediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Meoli, A., Fainardi, V., Deolmi, M., Chiopris, G., Marinelli, F., Caminiti, C., Esposito, S., and Pisi, G. (2021). State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators and Triple-Combination Therapy. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090928"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/ppul.23790","article-title":"Data that empower: The success and promise of CF patient registries","volume":"52","author":"Fink","year":"2017","journal-title":"Pediatr. Pulmonol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.biochem.75.103004.142532","article-title":"CFTR function and prospects for therapy","volume":"77","author":"Riordan","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"24857","DOI":"10.1038\/srep24857","article-title":"Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis","volume":"6","author":"Nielsen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/ppul.23544","article-title":"The CF Gastrointestinal Microbiome: Structure and Clinical Impact","volume":"51","author":"Rogers","year":"2016","journal-title":"Pediatr. Pulmonol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Frati, F., Salvatori, C., Incorvaia, C., Bellucci, A., Di Cara, G., Marcucci, F., and Esposito, S. (2019). The Role of the Microbiome in Asthma: The Gut-Lung Axis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20010123"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","article-title":"The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks","volume":"10","author":"Enaud","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrgastro.2012.144","article-title":"Microbial contact during pregnancy, intestinal colonization and human disease","volume":"9","author":"Rautava","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"F286","DOI":"10.1136\/archdischild-2012-302134","article-title":"Gut microbiota in preterm infants: Assessment and relevance to health and disease","volume":"98","author":"Berrington","year":"2013","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ballarini, S., Rossi, G.A., Principi, N., and Esposito, S. (2021). Dysbiosis in Pediatrics Is Associated with Respiratory Infections: Is There a Place for Bacterial-Derived Products?. Microorganisms, 9.","DOI":"10.3390\/microorganisms9020448"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ppul.24766","article-title":"Age and Environment Exposure Influence the Fecal Bacteriome of Young Childre with Cystic Fibrosis","volume":"55","author":"Loman","year":"2020","journal-title":"Pediatr. Pulmonol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Meeker, S.M., Mears, K.S., Sangwan, N., Brittnacher, M.J., Weiss, E.J., Treuting, P.M., Tolley, N., Pope, C.E., Hager, K.R., and Vo, A.T. (2020). 2020 Jan, CFTR dysregulation drives active selection of the gut microbiome. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008251"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Burke, D.G., Fouhy, F., and Harrison, M.J. (2017). The altered gut microbiota in adults with cystic fibrosis. BMC Microbiol., 17.","DOI":"10.1186\/s12866-017-0968-8"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Schippa, S., Iebba, V., Santangelo, F., Gagliardi, A., De Biase, R.V., Stamano, A., Bertasi, S., Lucarelli, M., Conte, M.P., and Quattrucci, S. (2013). Cystic fibrosis transmembrane conductance regulator (CFTR) allelic viariants relate to shifts in faecal microbiota of cystic fibrosis patients. PLoS ONE, 8.","DOI":"10.1371\/annotation\/a8b06cd3-c8a8-48fa-9748-b04fded4b963"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"17834","DOI":"10.1038\/s41598-018-36364-6","article-title":"Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation","volume":"8","author":"Ooi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jcf.2022.06.002","article-title":"Modulation, microbiota and inflammation in the adult CF gut: A prospective study","volume":"25","author":"Ronan","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e00274-19","DOI":"10.1128\/JB.00274-19","article-title":"Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth","volume":"201","author":"Antosca","year":"2019","journal-title":"J. Bacteriol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e00251-12","DOI":"10.1128\/mBio.00251-12","article-title":"Serial analysys of the gut and respiratory microbiome in CF in infancy: The interaction between intestinal and respiratory tracts and the impact of nutritional exposure","volume":"3","author":"Madan","year":"2012","journal-title":"mBio"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Vernocchi, P., Del Chierico, F., Russo, A., Majo, F., Rossitto, M., Valerio, M., Casadei, L., La Storia, A., De Filippis, F., and Rizzo, C. (2018). Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208171"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"De Freitas, M.B., Moreira, E.A.M., Tomio, C., Moreno, Y.M.F., Daltoe, F.P., Barbosa, E., Neto, N.L., Buccigrossi, V., and Guarino, A. (2018). Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198457"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcf.2020.04.007","article-title":"Development of the gut microbiota in early life: The impact of cistic fibrosis and antibiotic treatment","volume":"19","author":"Kristensen","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsuneko","year":"2012","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpeds.2016.08.044","article-title":"Advances in Gut Microbiome Research and Relevance to Pediatric Diseases","volume":"178","author":"Albenberg","year":"2016","journal-title":"J. Pediatr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1038\/s41598-018-25190-5","article-title":"Ketogenic diet enhances neurovascular function with altered gut microbiome in young healty mice","volume":"8","author":"Ma","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jamapediatrics.2015.3732","article-title":"Association of Cesarean delivery and formula supplementation with the intestinal microbiome of 6-week-old infants","volume":"170","author":"Madan","year":"2016","journal-title":"JAMA Paediatr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fcimb.2022.789436","article-title":"Microbiota profiles in pre-school children with respiratory infections: Modifications induced by the oral bacterial lysate OM-85","volume":"12","author":"Esposito","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1038\/s41598-017-06880-y","article-title":"A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis","volume":"7","author":"Fouhy","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1128\/AEM.05933-11","article-title":"Cross-Sectional and Longitudinal Composition of Prenominant Fecal Microbiota Composition of a Group of Pediatric Patients with Cystic Fibrosis and Their Healty Siblings","volume":"77","author":"Duytschaever","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4161\/viru.1.4.12010","article-title":"The human microbiome harbors a diverse reservoiur of antibiotic resistance genes","volume":"1","author":"Sommer","year":"2010","journal-title":"Virulence"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jcf.2013.06.006","article-title":"Amoxicillin\u2013clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings","volume":"12","author":"Duytschaever","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jcf.2020.11.009","article-title":"The cystic fibrosis gut as a potential source of multidrug resistant pathogens","volume":"20","author":"Taylor","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Thavamani, A., Salem, I., Sferra, T.J., and Sankararaman, S. (2021). Impact of Altered Gut Microbiota and Its Metabolites in Cystic Fibrosis. Metabolites, 11.","DOI":"10.3390\/metabo11020123"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cid\/cit715","article-title":"Escherichia coli Dysbiosis Correlates with Gastrointestinal Dysfunction in Children with Cystic Fibrosis","volume":"58","author":"Hoffman","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jcf.2012.03.007","article-title":"Gut dysbiosis in cystic fibrosis","volume":"11","author":"Scanlan","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bruzzese, E., Callegari, M.L., Raia, V., Viscovo, S., Scotto, R., Ferrari, S., Morelli, L., Buccigrossi, V., Lo Vecchio, A., and Ruberto, E. (2014). Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087796"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"18593","DOI":"10.1038\/s41598-019-55028-7","article-title":"Gut microbiota in children with cystic fibrosis: A taxonomic and functional dysbiosis","volume":"9","author":"Coffey","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e00311-21","DOI":"10.1128\/JB.00311-21","article-title":"The gut-lung axis in cystic fibrosis","volume":"203","author":"Price","year":"2021","journal-title":"J. Bacteriol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fmicb.2020.00301","article-title":"The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/nu3100858","article-title":"Regulation of inflammation by short chain faffy acids","volume":"3","author":"Vinolo","year":"2011","journal-title":"Nutrients"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Fran\u00e7oise, A., and H\u00e9ry-Arnaud, G. (2020). The Microbiome in Cystic Fibrosis Pulmonary Disease. Genes, 11.","DOI":"10.3390\/genes11050536"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jcf.2012.07.003","article-title":"Innate immunity in cystic fibrosis lung disease","volume":"11","author":"Hartl","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpeds.2015.02.049","article-title":"Association between gut microbial colonization in early life and respiratory outcomes in cystic fibrosis","volume":"167","author":"Hoen","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1365-2222.1999.00560.x","article-title":"The intestinal microflora in allergic Estonian and Swedish 2-year-old children","volume":"29","author":"Naaber","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1067\/mai.2001.111237","article-title":"Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing","volume":"107","author":"Kirjavainen","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cell.2005.05.007","article-title":"An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system","volume":"122","author":"Mazmanian","year":"2005","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcf.2012.10.003","article-title":"Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota","volume":"12","author":"Duytschaever","year":"2013","journal-title":"J. Cyst. FIbros."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Esposito, S., Testa, I., Mariotti Zani, E., Cunico, D., Torelli, L., Grandinetti, R., Fainardi, V., Pisi, G., and Principi, N. (2022). Probiotics Administration in Cystic Fibrosis: What Is the Evidence?. Nutrients, 14.","DOI":"10.3390\/nu14153160"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s40168-018-0566-5","article-title":"Neonatal gut and respiratory microbiota: Coordinated development through time and space","volume":"6","author":"Grier","year":"2018","journal-title":"Microbiome"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1249\/MSS.0000000000000344","article-title":"Prediction of mortality in adolescents with cystic fibrosis","volume":"46","author":"Hulzebos","year":"2014","journal-title":"Med. Sci. Sport. Exerc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41591-019-0714-x","article-title":"Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure","volume":"26","author":"Hayden","year":"2020","journal-title":"Nat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40168-015-0089-2","article-title":"Linear growth faltering in infants is associated with Acidaminococcus sp. and community-level changes in the gut microbiota","volume":"3","author":"Gough","year":"2015","journal-title":"Microbiome"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MPG.0b013e3181d1b013","article-title":"Evidence of intestinal inflammation in patients with cystic fibrosis","volume":"51","author":"Werlin","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/1\/9\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:44:57Z","timestamp":1760147097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/1\/9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["microorganisms11010009"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11010009","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]}}}